Data derived from PhenomiR
PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
18230780 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA overexpression |
- |
1.1 |
- |
Patient study phenotype-control |
quantitative PCR
|
18607389 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA overexpression |
- |
1.3 |
- |
Patient study phenotype-control |
quantitative PCR
|
18176954 |
Hepatocellular carcinoma - 114550 |
Cancer |
liver |
miRNA overexpression |
- |
1.42 |
- |
Patient study phenotype-phenotype |
miRNA microarray
|
17363563 |
Glioblastoma multiforme, somatic - 137800 |
Cancer |
U-251 cell |
miRNA downregulation |
- |
18.8 |
- |
Cell culture study |
quantitative PCR
|
18525125 |
Alzheimer disease, susceptibility to - 104300 |
Neurological |
cerebrospinal fluid |
miRNA downregulation |
- |
2.08 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18381414 |
Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) |
Cancer |
HSC-3 cell |
miRNA downregulation |
- |
- |
- |
Cell culture study |
quantitative PCR
|
18451220 |
Squamous cell carcinoma, head and neck - 601400 (Squamous cell carcinoma (SCC) of the tongue - 0) |
Cancer |
tongue |
miRNA overexpression |
- |
3.15 |
- |
Patient study phenotype-control |
quantitative PCR
|
18442408 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary cancer cell |
miRNA overexpression |
- |
7.7 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18187662 |
Leukemia, acute myelogenous - 601626 |
Cancer |
blood |
miRNA downregulation |
- |
3.23 |
- |
Patient study phenotype-control |
quantitative PCR
|
18537969 |
Non-Hodgkin lymphoma, somatic - 605027 |
Cancer |
lymph node |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
17976522 |
Myelofibrosis, idiopathic - 254450 |
Hematological |
granulocyte |
miRNA downregulation |
- |
2.32558 |
- |
Patient study phenotype-control |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
T-47D cell |
miRNA overexpression |
- |
2.34 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
SK-BR-3 cell |
miRNA overexpression |
- |
3.75 |
- |
Cell culture study |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA downregulation |
- |
2.43902 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA downregulation |
- |
2.71 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18223217 |
Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) |
Cancer |
liver |
miRNA overexpression |
- |
3.0 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18728182 |
Multiple myeloma - 254500 |
Cancer |
plasma cell |
miRNA downregulation |
- |
6.25 |
- |
Patient study phenotype-control |
miRNA microarray
|
16754881 |
Ovarian cancer - 604370 |
Cancer |
ovary |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
16754881 |
Breast cancer - 114480 |
Cancer |
breast epithelium |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
16754881 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
cell culture |
miRNA overexpression |
- |
- |
- |
Cell culture study |
array CGH
|
18756266 |
Medulloblastoma - 155255 (Medulloblastoma with high Gli1 expression - 0) |
Cancer |
cerebellum |
miRNA downregulation |
- |
25.0 |
- |
Patient study phenotype-control |
quantitative PCR
|
18756266 |
Medulloblastoma - 155255 (Medulloblastoma with low Gli1 expression - 0) |
Cancer |
cerebellum |
miRNA downregulation |
- |
2.04082 |
- |
Patient study phenotype-control |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MCF-7 cell |
miRNA overexpression |
- |
2.31 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA overexpression |
- |
2.14 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA overexpression |
- |
5.21 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PC-3 cell |
miRNA downregulation |
- |
1.0101 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PPC-1 cell |
miRNA downregulation |
- |
3.57143 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
DU-145 cell |
miRNA overexpression |
- |
1.97 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
Tsu-Pr1 cell |
miRNA downregulation |
- |
3.44828 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
LNCaP cell |
miRNA overexpression |
- |
1.17 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA overexpression |
- |
1.86 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
1.0989 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA overexpression |
- |
5.65 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
lung cancer cell line |
miRNA overexpression |
- |
2.11 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA overexpression |
- |
5.81 |
- |
Cell culture study |
quantitative PCR
|
18607389 |
- |
- |
embryo |
miRNA overexpression |
- |
1.57 |
- |
Bioprocess study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA overexpression |
- |
2.58 |
- |
Cell culture study |
quantitative PCR
|